LDN-051 A NOVEL FECAL BIOMARKER FOR MONITORING DISEASE ACTIVITY AND THERAPEUTIC RESPONSE IN INFLAMMATORY BOWEL DISEASES – RESULTS OF A PHASE 2 CLINICAL TRIAL

Boldizsár Jójárt  1     Tamás Resál  2     Diána Kata  2     Tünde Molnár  2, 3     Péter Bacsur  3     Viktória Szabó  2, 3, 4     Arpad Varga  2, 3, 4     Kata Szántó  4     Imre Földesi  4     Tamás Molnár  4     József Maléth  1, 2, 3, 5     Klaudia Farkas  5    
1 Ladon Therapeutics Ltd, Szeged, Hungary
2 University of Szeged, Szent-Györgyi Albert Medical School, Szeged, Hungary
3 ELKH-USz Momentum Epithelial Cell Signaling and Secretion Research Group, Szeged, Hungary
4 HCEMM-USz Molecular Gastroenterology Research Group, Szeged, Hungary
5 HCEMM-USz Molecular Gastroenterology Re

Topic
IBD

Conference
UEG Week 2023

Citation
United European Gastroenterology Journal 2023; 11 (Supplement 8)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Social Sharing